Insurance - Brokers
Compare Stocks
5 / 10Stock Comparison
GOCO vs HIMS vs TDOC vs ALHC vs AMWL
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Equipment & Services
Medical - Healthcare Information Services
Medical - Healthcare Plans
Medical - Healthcare Information Services
GOCO vs HIMS vs TDOC vs ALHC vs AMWL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Brokers | Medical - Equipment & Services | Medical - Healthcare Information Services | Medical - Healthcare Plans | Medical - Healthcare Information Services |
| Market Cap | $11M | $7.30B | $1.31B | $3.66B | $133M |
| Revenue (TTM) | $738M | $2.35B | $2.51B | $4.26B | $182M |
| Net Income (TTM) | $-199M | $128M | $-171M | $20M | $-88M |
| Gross Margin | 82.6% | 69.7% | 65.6% | 9.0% | 38.7% |
| Operating Margin | -40.7% | 4.6% | -7.6% | 0.8% | -50.6% |
| Forward P/E | — | 58.3x | — | 101.8x | — |
| Total Debt | $528M | $1.12B | $1.04B | $338M | $5M |
| Cash & Equiv. | $41M | $229M | $781M | $578M | $182M |
GOCO vs HIMS vs TDOC vs ALHC vs AMWL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| GoHealth, Inc. (GOCO) | 100 | 0.5 | -99.5% |
| Hims & Hers Health,… (HIMS) | 100 | 213.7 | +113.7% |
| Teladoc Health, Inc. (TDOC) | 100 | 4.0 | -96.0% |
| Alignment Healthcar… (ALHC) | 100 | 81.8 | -18.2% |
| American Well Corpo… (AMWL) | 100 | 2.3 | -97.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GOCO vs HIMS vs TDOC vs ALHC vs AMWL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GOCO plays a supporting role in this comparison — it may shine differently against other peers.
HIMS carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 188.5% 10Y total return vs ALHC's 3.6%
- 59.0% revenue growth vs AMWL's -2.0%
- Better valuation composite
- 5.5% margin vs AMWL's -48.2%
TDOC lags the leaders in this set but could rank higher in a more targeted comparison.
ALHC is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- beta 0.81
- Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
- Beta 0.81 vs HIMS's 2.48, lower leverage
- +16.3% vs GOCO's -89.1%
AMWL is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.31, Low D/E 1.8%, current ratio 3.37x
- Beta 1.31, current ratio 3.37x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 59.0% revenue growth vs AMWL's -2.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 5.5% margin vs AMWL's -48.2% | |
| Stability / Safety | Beta 0.81 vs HIMS's 2.48, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +16.3% vs GOCO's -89.1% | |
| Efficiency (ROA) | 6.0% ROA vs AMWL's -25.1%, ROIC 10.7% vs -95.1% |
GOCO vs HIMS vs TDOC vs ALHC vs AMWL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
GOCO vs HIMS vs TDOC vs ALHC vs AMWL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GOCO leads in 1 of 6 categories
HIMS leads 1 • ALHC leads 1 • TDOC leads 0 • AMWL leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — HIMS and ALHC each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ALHC is the larger business by revenue, generating $4.3B annually — 23.3x AMWL's $182M. HIMS is the more profitable business, keeping 5.5% of every revenue dollar as net income compared to AMWL's -48.2%. On growth, ALHC holds the edge at +33.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $738M | $2.3B | $2.5B | $4.3B | $182M |
| EBITDAEarnings before interest/tax | -$194M | $164M | $42M | $66M | -$59M |
| Net IncomeAfter-tax profit | -$199M | $128M | -$171M | $20M | -$88M |
| Free Cash FlowCash after capex | -$78M | $73M | $251M | $237M | -$42M |
| Gross MarginGross profit ÷ Revenue | +82.6% | +69.7% | +65.6% | +9.0% | +38.7% |
| Operating MarginEBIT ÷ Revenue | -40.7% | +4.6% | -7.6% | +0.8% | -50.6% |
| Net MarginNet income ÷ Revenue | -27.0% | +5.5% | -6.8% | +0.5% | -48.2% |
| FCF MarginFCF ÷ Revenue | -10.6% | +3.1% | +10.0% | +5.6% | -22.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -71.1% | +28.4% | -2.5% | +33.3% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -30.4% | -27.3% | +32.1% | +2.1% | +44.5% |
Valuation Metrics
GOCO leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, GOCO's 5.0x EV/EBITDA is more attractive than ALHC's 75.7x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11M | $7.3B | $1.3B | $3.7B | $133M |
| Enterprise ValueMkt cap + debt − cash | $499M | $8.2B | $1.6B | $3.4B | -$45M |
| Trailing P/EPrice ÷ TTM EPS | -1.38x | 55.43x | -6.36x | -4845.95x | -1.34x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 58.29x | — | 101.82x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 5.04x | 46.50x | 15.65x | 75.68x | — |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 3.11x | 0.52x | 0.93x | 0.53x |
| Price / BookPrice ÷ Book value/share | 0.02x | 13.50x | 0.92x | 19.80x | 0.52x |
| Price / FCFMarket cap ÷ FCF | — | 98.70x | 4.58x | 32.37x | — |
Profitability & Efficiency
HIMS leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
HIMS delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-64 for GOCO. AMWL carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.07x. On the Piotroski fundamental quality scale (0–9), TDOC scores 6/9 vs HIMS's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -64.4% | +23.7% | -12.4% | +11.5% | -33.5% |
| ROA (TTM)Return on assets | -15.3% | +6.0% | -5.9% | +1.8% | -25.1% |
| ROICReturn on invested capital | -0.6% | +10.7% | -11.5% | — | -95.1% |
| ROCEReturn on capital employed | -0.6% | +10.9% | -10.0% | +2.9% | -36.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.15x | 2.07x | 0.75x | 1.89x | 0.02x |
| Net DebtTotal debt minus cash | $487M | $892M | $259M | -$240M | -$178M |
| Cash & Equiv.Liquid assets | $41M | $229M | $781M | $578M | $182M |
| Total DebtShort + long-term debt | $528M | $1.1B | $1.0B | $338M | $5M |
| Interest CoverageEBIT ÷ Interest expense | -4.03x | — | -8.76x | 1.27x | -239.18x |
Total Returns (Dividends Reinvested)
ALHC leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIMS five years ago would be worth $27,393 today (with dividends reinvested), compared to $51 for GOCO. Over the past 12 months, ALHC leads with a +16.3% total return vs GOCO's -89.1%. The 3-year compound annual growth rate (CAGR) favors ALHC at 35.4% vs GOCO's -58.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -62.1% | -15.4% | +2.8% | -11.3% | +64.3% |
| 1-Year ReturnPast 12 months | -89.1% | -45.0% | +2.4% | +16.3% | +14.5% |
| 3-Year ReturnCumulative with dividends | -92.9% | +138.6% | -72.2% | +148.0% | -80.2% |
| 5-Year ReturnCumulative with dividends | -99.5% | +173.9% | -94.9% | -16.6% | -96.9% |
| 10-Year ReturnCumulative with dividends | -99.7% | +188.5% | -38.7% | +3.6% | -98.3% |
| CAGR (3Y)Annualised 3-year return | -58.7% | +33.6% | -34.7% | +35.4% | -41.7% |
Risk & Volatility
Evenly matched — ALHC and AMWL each lead in 1 of 2 comparable metrics.
Risk & Volatility
ALHC is the less volatile stock with a 0.81 beta — it tends to amplify market swings less than HIMS's 2.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMWL currently trades 87.1% from its 52-week high vs GOCO's 10.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.12x | 2.48x | 1.89x | 0.81x | 1.31x |
| 52-Week HighHighest price in past year | $8.75 | $70.43 | $9.77 | $23.87 | $9.15 |
| 52-Week LowLowest price in past year | $0.90 | $13.74 | $4.40 | $11.63 | $3.71 |
| % of 52W HighCurrent price vs 52-week peak | +10.4% | +40.1% | +74.2% | +75.1% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 34.0 | 50.2 | 76.1 | 38.1 | 72.3 |
| Avg Volume (50D)Average daily shares traded | 79K | 34.8M | 5.2M | 3.6M | 60K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: HIMS as "Hold", TDOC as "Hold", ALHC as "Buy", AMWL as "Hold". Consensus price targets imply 38.5% upside for ALHC (target: $25) vs -27.9% for AMWL (target: $6).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $26.20 | $7.58 | $24.83 | $5.75 |
| # AnalystsCovering analysts | — | 19 | 42 | 16 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 2 | — | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +13.1% | +1.2% | 0.0% | 0.0% | +0.0% |
GOCO leads in 1 of 6 categories (Valuation Metrics). HIMS leads in 1 (Profitability & Efficiency). 2 tied.
GOCO vs HIMS vs TDOC vs ALHC vs AMWL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GOCO or HIMS or TDOC or ALHC or AMWL a better buy right now?
For growth investors, Hims & Hers Health, Inc.
(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -2. 0% for American Well Corporation (AMWL). Hims & Hers Health, Inc. (HIMS) offers the better valuation at 55. 4x trailing P/E (58. 3x forward), making it the more compelling value choice. Analysts rate Alignment Healthcare, Inc. (ALHC) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GOCO or HIMS or TDOC or ALHC or AMWL?
On forward P/E, Hims & Hers Health, Inc.
is actually cheaper at 58. 3x.
03Which is the better long-term investment — GOCO or HIMS or TDOC or ALHC or AMWL?
Over the past 5 years, Hims & Hers Health, Inc.
(HIMS) delivered a total return of +173. 9%, compared to -99. 5% for GoHealth, Inc. (GOCO). Over 10 years, the gap is even starker: HIMS returned +188. 5% versus GOCO's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GOCO or HIMS or TDOC or ALHC or AMWL?
By beta (market sensitivity over 5 years), Alignment Healthcare, Inc.
(ALHC) is the lower-risk stock at 0. 81β versus Hims & Hers Health, Inc. 's 2. 48β — meaning HIMS is approximately 207% more volatile than ALHC relative to the S&P 500. On balance sheet safety, American Well Corporation (AMWL) carries a lower debt/equity ratio of 2% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GOCO or HIMS or TDOC or ALHC or AMWL?
By revenue growth (latest reported year), Hims & Hers Health, Inc.
(HIMS) is pulling ahead at 59. 0% versus -2. 0% for American Well Corporation (AMWL). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GOCO or HIMS or TDOC or ALHC or AMWL?
Hims & Hers Health, Inc.
(HIMS) is the more profitable company, earning 5. 5% net margin versus -38. 4% for American Well Corporation — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HIMS leads at 5. 2% versus -42. 2% for AMWL. At the gross margin level — before operating expenses — GOCO leads at 83. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GOCO or HIMS or TDOC or ALHC or AMWL more undervalued right now?
On forward earnings alone, Hims & Hers Health, Inc.
(HIMS) trades at 58. 3x forward P/E versus 101. 8x for Alignment Healthcare, Inc. — 43. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALHC: 38. 5% to $24. 83.
08Which pays a better dividend — GOCO or HIMS or TDOC or ALHC or AMWL?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is GOCO or HIMS or TDOC or ALHC or AMWL better for a retirement portfolio?
For long-horizon retirement investors, Alignment Healthcare, Inc.
(ALHC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 81)). GoHealth, Inc. (GOCO) carries a higher beta of 2. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALHC: +3. 6%, GOCO: -99. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GOCO and HIMS and TDOC and ALHC and AMWL?
These companies operate in different sectors (GOCO (Financial Services) and HIMS (Healthcare) and TDOC (Healthcare) and ALHC (Healthcare) and AMWL (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GOCO is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; TDOC is a small-cap quality compounder stock; ALHC is a small-cap high-growth stock; AMWL is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.